You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.6% | 0.6% |
| Div Cover | 8.1 | 8.3 |
| Op Mrgn | 10.9% | 20.2% |
| ROCE | 75.9% |
| Latest | Forecast | |
|---|---|---|
| P/E | 20.9 | 17.9 |
| PEG | 2.1 | 0.9 |
| Price / Revenue | 3.3 | 2.8 |
| Price / Book value | 3.6 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 26.1% | 0.0% |
| PBT | 154.6% | n/a |
| EPS | 9.9% | 0.0% |
| DPS | 12.0% | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2015-06-30 | 184.40 | 8.30 | 28.00p | 22.3 | 1.6 | 14% | 3.40p | 0.5% |
| 2016-06-30 | 339.90 | 15.90 | 33.40p | 18.1 | 0.9 | 19% | 4.00p | 0.7% |
| 2017-06-30 | 302.30 | 14.10 | 41.30p | 20.8 | 0.9 | 24% | 5.00p | 0.6% |
| 2018-06-30 | 381.20 | 35.90 | 45.40p | 20.2 | 2.0 | 10% | 5.60p | 0.6% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2019-06-30 | 445.74 | 89.86 | 53.46p | 17.9 | 1.0 | 18% | 6.41p | 0.7% |
| 2020-06-30 | 528.82 | 127.70 | 74.92p | 12.9 | 0.3 | 40% | 8.60p | 0.9% |
| Clinigen expects revenue boost from new acquisitions Sharecast News | 16 Jul |
|---|---|
| Clinigen to take back US rights to cancer drugs Sharecast News | 15 May |
| Clinigen monopolises global rights for skin cancer treatment Sharecast News | 02 Apr |
| Year end trading update | 16-Jul-19 07:02 |
|---|---|
| Total Voting Rights | 28-Jun-19 11:01 |
| Issue of Equity | 03-Jun-19 09:01 |
| Holding(s) in Company | 28-May-19 18:03 |
| US commercial rights of Ethyol® and Totect® | 15-May-19 07:05 |